PALB2 and hypoparathyroidism-retardation-dysmorphism syndrome: Since then, additional genes involved in the HR-pathway, such as PALB2, ATM, and CHECK2 [16], have been identified, and a clear link between HRD and breast, ovarian, prostate, and pancreatic cancer has been established.